Skip to main content

Table 2 Demographic and comorbidity distribution of patients by severity level

From: Value of peripheral blood eosinophil markers to predict severity of asthma

Patient characteristics

Asthma Severity

p-value

Mild (n = 457)

Moderate-to-severe (n = 687)

 

N (%)

N (%)

 

Gender

   

 Female

312 (68.27)

499 (72.63)

0.116

Race

   

 White

222 (48.58)

340 (49.49)

0.821

 Black

59 (12.91)

81 (11.79)

 Hispanic

109 (23.85)

155 (22.56)

 Other/Unknown

67 (14.66)

111 (16.16)

Age groups

   

 12–17 years

80 (17.51)

36 (5.24)

<0.0001

 18–35 years

78 (17.07)

113 (16.45)

 36–64 years

232 (50.77)

401 (58.37)

 Greater than/equal to 65 years

67 (14.66)

137 (19.94)

Top 5 Comorbidities

   

 Diabetes

53 (11.60)

107 (15.57)

0.057

 Cancer/tumor

35 (7.66)

38 (5.33)

0.149

 Congestive Heart Failure

23 (5.03)

45 (6.55)

0.288

 Cerebrovascular disease

13 (2.84)

19 (2.77)

0.937

 Renal disease

8 (1.75)

20 (2.91)

0.213

CCI Score Mean (SD)

1.49 (1.16)

1.52 (1.14)

0.701